Stockholders Equity (Details) - Schedule of outstanding and exercisable warrants - $ / shares |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Schedule of outstanding and exercisable warrants [Abstract] | ||||
| Numbers of Warrants Outstanding ,Beginning Balance | 10,345,784 | |||
| Weighted Average Exercise Price , Beginning Balance | $ 4.9 | |||
| Weighted Average Life (Years) , Beginning Balance | ||||
| Numbers of Warrants Outstanding , Warrants Issued | 10,733,651 | |||
| Weighted Average Exercise Price , Warrants Issued | $ 4.9 | |||
| Weighted Average Life (Years) , Warrants Issued | ||||
| Numbers of Warrants Outstanding , Warrants Exercised | (271,589) | (387,867) | ||
| Weighted Average Exercise Price , Warrants Exercised | $ 4.9 | |||
| Weighted Average Life (Years) , Warrants Exercised | ||||
| Numbers of Warrants Outstanding , Ending Balance | 10,074,195 | 10,345,784 | ||
| Weighted Average Exercise Price , Ending Balance | $ 4.9 | $ 4.9 | ||
| Weighted Average Life (Years) | 5 years | 5 years | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|